Literature DB >> 10767827

Epidemiology and molecular typing of an outbreak of tuberculosis in a hostel for homeless men.

A M Kearns1, A Barrett, C Marshall, R Freeman, J G Magee, S J Bourke, M Steward.   

Abstract

AIM: To investigate a possible outbreak of tuberculosis in a hostel for homeless men using IS6110 profiling, a polymerase chain reaction (PCR) based fingerprinting technique.
METHODS: Eight cases of tuberculosis were diagnosed in residents of the hostel over a period of 28 months. To provide epidemiological data, a heminested inverse PCR (HIP) assay targeting the insertion sequence IS6110 together with its upstream flanking region was used to fingerprint the eight isolates of M tuberculosis under investigation.
RESULTS: The HIP technique gave IS6110 profiles which showed that while three isolates were clearly distinct, the remaining five strains were indistinguishable, suggesting the latter were representatives of a single outbreak strain.
CONCLUSIONS: The HIP assay proved discriminatory and facilitated repeated testing for the direct comparison of strains as more patients presented over the protracted course of this outbreak.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767827      PMCID: PMC1763283          DOI: 10.1136/jcp.53.2.122

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

Review 1.  Strain typing of Mycobacterium tuberculosis.

Authors:  N A Saunders
Journal:  J Infect       Date:  1999-03       Impact factor: 6.072

Review 2.  State of the art: typing Mycobacterium tuberculosis.

Authors:  N A Saunders
Journal:  J Hosp Infect       Date:  1995-03       Impact factor: 3.926

3.  Tuberculosis in Britain today.

Authors:  J M Watson
Journal:  BMJ       Date:  1993-01-23

4.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Heminested inverse PCR for IS6110 fingerprinting of Mycobacterium tuberculosis strains.

Authors:  S Patel; S Wall; N A Saunders
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

6.  Investigation of an outbreak of multidrug resistant tuberculosis among renal patients using rpo B gene sequencing and IS6110 inverse PCR.

Authors:  N A Saunders; L Metherell; S Patel
Journal:  J Infect       Date:  1997-09       Impact factor: 6.072

7.  Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli.

Authors:  M A Behr; S A Warren; H Salamon; P C Hopewell; A Ponce de Leon; C L Daley; P M Small
Journal:  Lancet       Date:  1999-02-06       Impact factor: 79.321

8.  An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital.

Authors:  A S Breathnach; A de Ruiter; G M Holdsworth; N T Bateman; D G O'Sullivan; P J Rees; D Snashall; H J Milburn; B S Peters; J Watson; F A Drobniewski; G L French
Journal:  J Hosp Infect       Date:  1998-06       Impact factor: 3.926

9.  Tuberculosis among the homeless at a temporary shelter in London: report of a chest x ray screening programme.

Authors:  D Kumar; K M Citron; J Leese; J M Watson
Journal:  J Epidemiol Community Health       Date:  1995-12       Impact factor: 3.710

  9 in total
  2 in total

1.  Discriminatory power and reproducibility of novel DNA typing methods for Mycobacterium tuberculosis complex strains.

Authors:  Kristin Kremer; Catherine Arnold; Angel Cataldi; M Cristina Gutiérrez; Walter H Haas; Stefan Panaiotov; Robin A Skuce; Philip Supply; Adri G M van der Zanden; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 2.  Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria.

Authors:  Tomasz Jagielski; Jakko van Ingen; Nalin Rastogi; Jarosław Dziadek; Paweł K Mazur; Jacek Bielecki
Journal:  Biomed Res Int       Date:  2014-01-05       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.